LEGN (Legend Biotech) Beginning Cash Position : $201.3 Mil (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Legend Biotech Beginning Cash Position?

Legend Biotech's Beginning Cash Position for the quarter that ended in Sep. 2024 was $201.3 Mil.

Legend Biotech's quarterly Beginning Cash Position declined from Mar. 2024 ($1,277.7 Mil) to Jun. 2024 ($897.6 Mil) and declined from Jun. 2024 ($897.6 Mil) to Sep. 2024 ($201.3 Mil).

Legend Biotech's annual Beginning Cash Position increased from Dec. 2021 ($455.7 Mil) to Dec. 2022 ($688.9 Mil) and increased from Dec. 2022 ($688.9 Mil) to Dec. 2023 ($786.0 Mil).

Legend Biotech Beginning Cash Position Historical Data

The historical data trend for Legend Biotech's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Legend Biotech Beginning Cash Position Chart

Legend Biotech Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

210.17

83.36

455.69

688.94

786.03

Legend Biotech Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Beginning Cash Position	Get a 7-Day Free Trial															1,233.21	963.47	1,277.71	897.57	201.25

Legend Biotech Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Legend Biotech Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Legend Biotech's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Legend Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Legend Biotech Corp (NAS:LEGN) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

9LB:Germany

Address

2101 Cottontail Lane, Somerset, NJ, USA, 08873

Website

https://www.legendbiotech.com

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.